BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25120723)

  • 1. 10058-F4, a c-Myc inhibitor, markedly increases valproic acid-induced cell death in Jurkat and CCRF-CEM T-lymphoblastic leukemia cells.
    Mu Q; Ma Q; Lu S; Zhang T; Yu M; Huang X; Chen J; Jin J
    Oncol Lett; 2014 Sep; 8(3):1355-1359. PubMed ID: 25120723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibitors synergistically potentiate death receptor 4-mediated apoptotic cell death of human T-cell acute lymphoblastic leukemia cells.
    Sung ES; Kim A; Park JS; Chung J; Kwon MH; Kim YS
    Apoptosis; 2010 Oct; 15(10):1256-69. PubMed ID: 20582477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis induced by the histone deacetylase inhibitor sodium butyrate in human leukemic lymphoblasts.
    Bernhard D; Ausserlechner MJ; Tonko M; Löffler M; Hartmann BL; Csordas A; Kofler R
    FASEB J; 1999 Nov; 13(14):1991-2001. PubMed ID: 10544182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GAS2 Promotes Cell Proliferation and Invasion and Suppresses Apoptosis in Pediatric T-Cell Acute Lymphoblastic Leukemia and Activates Wnt/β-Catenin Pathway.
    Kong Y; Zhao S; Tian H; Hai Y
    Onco Targets Ther; 2020; 13():1099-1108. PubMed ID: 32103979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch1 receptor regulates AKT protein activation loop (Thr308) dephosphorylation through modulation of the PP2A phosphatase in phosphatase and tensin homolog (PTEN)-null T-cell acute lymphoblastic leukemia cells.
    Hales EC; Orr SM; Larson Gedman A; Taub JW; Matherly LH
    J Biol Chem; 2013 Aug; 288(31):22836-48. PubMed ID: 23788636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beauvericin induces cytotoxic effects in human acute lymphoblastic leukemia cells through cytochrome c release, caspase 3 activation: the causative role of calcium.
    Jow GM; Chou CJ; Chen BF; Tsai JH
    Cancer Lett; 2004 Dec; 216(2):165-73. PubMed ID: 15533592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental study on the mechanism of the apoptosis of leukemic cells induced by valproic acid].
    Xue HM; Li WY; Guo HX; Xia Y; Chen Q; Liu Y
    Zhonghua Er Ke Za Zhi; 2005 Dec; 43(12):894-8. PubMed ID: 16412349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc.
    Sharma VM; Calvo JA; Draheim KM; Cunningham LA; Hermance N; Beverly L; Krishnamoorthy V; Bhasin M; Capobianco AJ; Kelliher MA
    Mol Cell Biol; 2006 Nov; 26(21):8022-31. PubMed ID: 16954387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecule inhibitor of c-Myc 10058-F4 inhibits proliferation and induces apoptosis in acute leukemia cells, irrespective of PTEN status.
    Bashash D; Sayyadi M; Safaroghli-Azar A; Sheikh-Zeineddini N; Riyahi N; Momeny M
    Int J Biochem Cell Biol; 2019 Mar; 108():7-16. PubMed ID: 30639430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of c-Myc using 10058-F4 exerts caspase-3-dependent apoptosis and intensifies the antileukemic effect of vincristine in pre-B acute lymphoblastic leukemia cells.
    Sheikh-Zeineddini N; Bashash D; Safaroghli-Azar A; Riyahi N; Shabestari RM; Janzamin E; Safa M
    J Cell Biochem; 2019 Aug; 120(8):14004-14016. PubMed ID: 30957273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of c-Myc is critical for valproic acid-induced growth arrest and myeloid differentiation of acute myeloid leukemia.
    Cheng YC; Lin H; Huang MJ; Chow JM; Lin S; Liu HE
    Leuk Res; 2007 Oct; 31(10):1403-11. PubMed ID: 17445886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Statins Regulate the Proliferation and Apoptosis of T-ALL Cells through the Inhibition of Akt Pathway].
    Wang JJ; Tian Y; Xu KL; Fu RX; Niu MS; Zhao K
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):359-367. PubMed ID: 29665899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of c-MYC with involvement of ERK/JNK/MAPK and AKT pathways as a novel mechanism for shikonin and its derivatives in killing leukemia cells.
    Zhao Q; Assimopoulou AN; Klauck SM; Damianakos H; Chinou I; Kretschmer N; Rios JL; Papageorgiou VP; Bauer R; Efferth T
    Oncotarget; 2015 Nov; 6(36):38934-51. PubMed ID: 26472107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyper-activation of WNT/β-catenin signaling pathway mediates anti-tumor effects of histone deacetylase inhibitors in acute T lymphoblastic leukemia.
    Shao N; Zou J; Li J; Chen F; Dai J; Qu X; Sun X; Ma D; Ji C
    Leuk Lymphoma; 2012 Sep; 53(9):1769-78. PubMed ID: 22303878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of ceramide metabolism in T-leukemia cell lines potentiates apoptosis induced by the cationic antimicrobial peptide bovine lactoferricin.
    Furlong SJ; Ridgway ND; Hoskin DW
    Int J Oncol; 2008 Mar; 32(3):537-44. PubMed ID: 18292930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of valproic acid and pioglitazone on cell cycle progression and proliferation of T-cell acute lymphoblastic leukemia Jurkat cells.
    Jazi MS; Mohammadi S; Yazdani Y; Sedighi S; Memarian A; Aghaei M
    Iran J Basic Med Sci; 2016 Jul; 19(7):779-86. PubMed ID: 27635203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic and apoptotic effects of prenylflavonoid artonin B in human acute lymphoblastic leukemia cells.
    Lee CC; Lin CN; Jow GM
    Acta Pharmacol Sin; 2006 Sep; 27(9):1165-74. PubMed ID: 16923337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential involvement of reactive oxygen species in apoptosis caused by the inhibition of protein phosphatase 2A in Jurkat and CCRF-CEM human T-leukemia cells.
    Boudreau RT; Conrad DM; Hoskin DW
    Exp Mol Pathol; 2007 Dec; 83(3):347-56. PubMed ID: 17936751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic interactions of cytarabine-adavosertib in leukemic cell lines proliferation and metabolomic endpoints.
    Rodríguez-Vázquez GO; Diaz-Quiñones AO; Chorna N; Salgado-Villanueva IK; Tang J; Ortiz WIS; Maldonado HM
    Biomed Pharmacother; 2023 Oct; 166():115352. PubMed ID: 37633054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
    De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J
    Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.